Dyne Therapeutics, Inc Earnings

Dyne Therapeutics, Inc’s revenue jumped NaN% since last year same period to $0Mn in the Q3 2025. On a quarterly growth basis, Dyne Therapeutics, Inc has generated NaN% jump in its revenue since last 3-months.

Dyne Therapeutics, Inc’s net profit fell -11.24% since last year same period to $-108.04Mn in the Q3 2025. On a quarterly growth basis, Dyne Therapeutics, Inc has generated 2.54% jump in its net profits since last 3-months.

Dyne Therapeutics, Inc’s net profit margin jumped NaN% since last year same period to -Inf% in the Q3 2025. On a quarterly growth basis, Dyne Therapeutics, Inc has generated NaN% jump in its net profit margins since last 3-months.

Dyne Therapeutics, Inc’s earning per share (EPS) estimates for the current quarter stand at -0.83 - a -7.47% fall from last quarter’s estimates.

Dyne Therapeutics, Inc’s earning per share (EPS) estimates for the current year stand at -0.83.

Dyne Therapeutics, Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q1 2026. This indicates that the Dyne Therapeutics, Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.